Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Pathogenesis and Immunity

Expression of the Mouse Hepatitis Virus Receptor by Central Nervous System Microglia

Chandran Ramakrishna, Cornelia C. Bergmann, Kathryn V. Holmes, Stephen A. Stohlman
Chandran Ramakrishna
1Departments of Neurology
2Pathology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cornelia C. Bergmann
1Departments of Neurology
2Pathology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathryn V. Holmes
3Department of Microbiology, University of Colorado Health Science Center, Denver, Colorado 80262
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen A. Stohlman
1Departments of Neurology
2Pathology
4Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California 90033
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: stohlman@usc.edu
DOI: 10.1128/JVI.78.14.7828-7832.2004
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Detection of the mouse hepatitis virus receptor within the central nervous system (CNS) has been elusive. Receptor expression on microglia was reduced during acute infection and restored following immune-mediated virus control. Receptor down regulation was independent of neutrophils, NK cells, gamma interferon, or perforin. Infection of mice devoid of distinct inflammatory cells revealed CD4+ T cells as the major cell type influencing receptor expression by microglia. In addition to demonstrating receptor expression on CNS resident cells, these data suggest that transient receptor down regulation on microglia aids in establishing persistence in the CNS by assisting virus infection of other glial cell types.

Interactions between the mouse hepatitis virus (MHV) spike (S) protein and the virus receptor influences tropism, spread, and pathogenesis (8, 17). The primary MHV receptor is the four-immunoglobulin isoform of CEACAM1a (1, 4). Low-affinity binding to related molecules and receptor-independent infection in vitro have also been described (5, 7, 9, 25-27). Despite limited in vitro receptor usage by the neurotropic JHM strain of MHV (JHMV) (5, 25, 27), central nervous system (CNS) ependymal cells, microglia, oligodendroglia, astrocytes, and neurons are infected in vivo (22). Low levels of MHV receptor mRNA are expressed by the CNS (5, 24). However, no receptor was identified by a direct binding assay (23), and only CNS endothelial cells, but not glial cells, expressed the receptor by immunohistochemistry (10). The absence of CNS expression led to proposals of alternate lower-affinity receptors (5) or a receptor-independent mechanism of virus infection (15). To resolve this issue, CEACAM1a expression on CD45low microglia isolated from the CNS of adult mice was examined. CNS mononuclear cells were isolated from homogenates by using a Percoll step gradient as described previously (2, 3). CNS-derived cells were labeled with phycoerythrin, fluorescein isothiocyanate, or allophycocyanin-labeled monoclonal antibodies (MAb) specific for CD45 (30-F11), CD4 (RM4-5), CD8 (53-6.7), MHC class II I-A/I-E (2G9), Ly-6G (1A8), CD11b (M1/70) (BD PharMingen, San Diego, Calif.), and F4/80 (Serotec, Raleigh, N.C.). Receptor expression was detected by using biotinylated MAb CC-1 (23) and phycoerythrin-conjugated avidin. Biotinylated immunoglobulin G1 (BD PharMingen) was used as an isotype control. Cells were analyzed on a FACS Calibur flow cytometer (Becton Dickinson, San Jose, Calif.), using Cellquest software. CEACAM1a was expressed by microglia from naïve susceptible C57BL/6 and BALB/c mice but not by microglia from resistant SJL mice (National Cancer Institute, Fredrick, Md.) (Fig. 1).

Microglia from BALB/c mice infected intracerebrally with 500 PFU of the J.2.2v-1 MAb-derived variant of JHMV (8) were examined at various times postinfection (p.i.). Whereas receptor expression was unaltered at 5 days p.i, expression decreased at 7 days p.i. based on mean fluorescence intensity (MFI) (Fig. 2A). The majority of microglia regained CEACAM1a expression by day 14 p.i. (Fig. 2A), and this expression returned to uninfected levels by day 30 p.i. (data not shown) concomitantly with virus clearance and partial resolution of inflammation. Similarly, microglia from C57BL/6 mice infected with 250 PFU of JHMV also exhibited reduced receptor expression by 7 days p.i. (Fig. 2B). Although down regulation was protracted in infected C57BL/6 mice compared to BALB/c mice (Fig. 2A and B), receptor was reexpressed at naïve levels by day 30 p.i. (Fig. 2B). These results suggest that either virus or inflammation regulates microglia receptor expression. Intracellular S protein-receptor interaction (18) or extracellular progeny could inhibit receptor detection. Sequestration appears unlikely, as only a small fraction of microglia are infected (22). To distinguish between a viral effect and inflammation, receptor expression was investigated during uncontrolled virus replication in mice immunosuppressed by irradiation (850 rad) 24 h prior to infection (16, 28) and in immunodeficient SCID mice (3). At day 7 p.i., receptor expression on microglia from infected irradiated BALB/c mice (Fig. 3A) and C57BL/6 mice (data not shown) was equivalent to that on microglia from naïve mice. No loss in receptor expression was noted in a limited number of survivors at day 9 p.i. (data not shown). CD45high inflammatory cells (Fig. 3D) were below the detection level (16, 28). Unaltered receptor expression despite uncontrolled virus replication (16, 28) indicates that neither intracellular trapping, extracellular binding of viral particles, nor soluble S protein masks receptor detection.

CNS infection induces the recruitment of innate and adaptive immune components (2, 3, 29). SCID mice were infected with 500 PFU of JHMV to determine whether neutrophils, NK cells, or macrophages regulate receptor expression (Fig. 3D). Microglia from uninfected and infected SCID mice exhibited no difference in receptor expression at 7 days p.i. (Fig. 3B) or at 10 days p.i. (data not shown). These data confirm that decreased receptor expression is not associated with virus replication and suggest that neutrophils, matrix metalloprotease-9 secretion (29), NK cells, and macrophages are not sufficient to influence receptor expression. To test gamma interferon (IFN-γ) secretion and perforin-mediated cytolysis as potential mediators, mice deficient in both functions (PKO/GKO mice) (2) were infected with 500 PFU of JHMV. Receptor expression on microglia from infected PKO/GKO mice was decreased at day 7 p.i. (Fig. 3C), indicating that neither of these anti-viral effector mechanisms are sufficient to mediate decreased receptor expression.

The fact that receptor expression in infected SCID mice was distinct from that in infected PKO/GKO mice suggested a link between T-cell infiltration and reduced receptor levels. Mice were therefore depleted of CD4+ T cells (MAb GK1.5) or CD8+ T cells (MAb 2.43) by MAb treatment on days −1, +1, and + 3 relative to infection (Fig. 4A). Controls received anti-β-galactosidase MAb GL113. The majority of microglia isolated from infected CD4+-T-cell-deficient mice at day 7 p.i. retained receptor expression compared to controls (Fig. 4B). Receptor loss was less severe on microglia from CD8+-T-cell-depleted mice (Fig. 4B), despite CD4+-T-cell accumulation in the CNS similar to that for infected controls (data not shown). CD45high CD11b+/class II+ macrophages from the CNS of CD4+-T-cell-deficient mice also retained receptor expression at 7 days p.i., while a minority of macrophages within the CNS of CD8-deficient mice exhibited decreased expression (Fig. 4C). These data indicate that CD4+ T cells and, to a lesser extent, CD8+ T cells influence the loss of receptor expression on both microglia and infiltrating macrophages.

Regulation of receptor expression by T cells appears to be a novel method by which immune responses influence the course of viral infection in an immune-privileged site via inhibition of attachment and entry. While protective, cytotoxic mechanisms in the CNS also induce immune-mediated pathology (3), decreased microglial susceptibility may thus be a mechanism to avoid overt immune pathology. The mechanism(s) by which CD4+ T cells regulate receptor expression on microglia is unclear but is likely to involve soluble factors, although the possibility of a reversible conformational change cannot be ruled out. JHMV infection results in the release of proinflammatory cytokines, chemokines, and matrix metalloproteinases (13, 16, 28). Analysis of IFN-γ-deficient mice excluded the possibility of a role for IFN-γ in receptor regulation in vivo, despite contradicting in vitro studies (21). IFN-α/β mRNA is also increased in the CNS of immunodeficient mice (unpublished observation), suggesting no correlation with receptor down regulation. However, unlike many potential proinflammatory cytokines that are decreased prior to diminished receptor expression (16), RANTES is maintained until JHMV infection and inflammation resolve (13), correlating with the transient down regulation of CEACAM1a on microglia. Reduced receptor expression occurs as infectious virus declines and thus may contribute to the limiting of virus spread, cytopathology, and potential glial cell-mediated damage. Viral persistence in vitro is associated with both reduced cytopathology (19, 20) and reduced receptor expression (6, 19), while increased expression enhances virus-induced cytopathology (18). Receptor down regulation in vivo appears to be widespread, although only a few microglia or macrophages are infected (22). Down regulation may be specific for only microglia and macrophages, thereby facilitating the infection of other glial cell types not responsive to receptor down regulation. Alternatively, reduced expression may modulate lymphocyte function. CEACAM1a signaling increases T-cell chemotaxis and cytokine secretion (12, 14) as well as B-cell activation (11). Thus, reduced receptor on CNS resident antigen-presenting cells may reduce T-cell recruitment, cytokine secretion, and possibly cytolysis in an attempt to limit immune-mediated pathology.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

CEACAM1a expression on microglia from adult mice. Single-cell brain suspensions from naïve mice were stained with anti-CD45, anti-CEACAM1a, or isotype control MAb. In the top row are representative density plots showing forward-side scatter and staining patterns. R1 indicates the live cell gate used for analysis. CD45 expression differentiates CD45low microglia and CD45high infiltrating cells (combined in R2). R3 and R4 highlight CD45low microglia stained with CC-1 or isotype control MAb. Shown in the bottom row is CEACAM1a expression (light lines) on microglia from C57Bl/6 and BALB/c mice but not SJL mice (R3). Dark lines represent isotype control MAb (R4); numbers are MFI values for CEACAM1a (right) and the isotype control (left).

FIG. 2.
  • Open in new tab
  • Download powerpoint
FIG. 2.

CEACAM1a expression on microglia is down regulated following JHMV infection. CD45low microglia from naïve mice compared with those from infected BALB/c (A) or C57Bl/6 (B) mice at days 5, 7, 14 and 30 p.i. were analyzed for CEACAM1a expression. The number above each histogram is the number of days p.i. Regions and gates are described in Fig. 1. Numbers in the upper parts of the histograms are MFI values for MAb CC1 (right) and the isotype control (left). Percentages of microglia positive for CEACAM1a expression are given in the bottom parts of the histograms. The data presented are representative of three to five experiments.

FIG. 3.
  • Open in new tab
  • Download powerpoint
FIG. 3.

CEACAM1a expression on microglia from immunodeficient mice. (A to C) CD45low microglia isolated from naïve (left) or infected irradiated BALB/c (A), SCID (B), or PKO/GKO (C) mice at day 7 p.i. (right) stained for CEACAM1a (light line) or the isotype control (dark line). Regions and gates are described in Fig. 1. Numbers in the upper parts of the histograms are MFI values for CEACAM1a (right) or the isotype control (left). Percentages of microglia expressing CEACAM1a are given in the bottom right parts of the histograms. (D) Percentages of CD45high infiltrating cells and distinct phenotypic populations in irradiated BALB/c (IR), SCID, and PKO/GKO mice at 7 days p.i. The data presented are representative of three to five experiments.

FIG. 4.
  • Open in new tab
  • Download powerpoint
FIG. 4.

CEACAM1a expression on microglia and macrophages is regulated by CD4+ T cells. Mice were treated with anti-CD4, anti-CD8, or control MAb. CNS cells from infected CD4-depleted (CD4−; left), CD8-depleted (CD8−; middle), or control (CTRL; right) mice confirm the absence of specific cell types (A). Percentages of CD4+ or CD8+ T cells within the CNS infiltrates are indicated. CD45low microglia (B) or CD45high infiltrating CD11b+/class II+ macrophages (C) at day 7 p.i. were analyzed for CEACAM1a expression. In panels B and C, numbers in the upper parts of the histograms are MFI values and percentages in the bottom right parts of the histograms are those of cells expressing CEACAM1a. The data presented represent one of three similar experiments.

ACKNOWLEDGMENTS

This work was supported by National Institutes of Health grants NS18146, NS40667, AI47248, and AI25231.

FOOTNOTES

    • Received 23 December 2003.
    • Accepted 9 March 2004.
  • Copyright © 2004 American Society for Microbiology

REFERENCES

  1. 1.↵
    Beauchemin, N., P. Draber, G. Dveksler, P. Gold, S. Gray-Owen, F. Grunert, S. Hammarstrom, K. V. Holmes, A. Karlsson, M. Kuroki, S. H. Lin, L. Lucka, S. M. Najjar, M. Neumaier, B. Obrink, J. E. Shively, K. M. Skubitz, C. P. Stanners, P. Thomas, J. A. Thompson, M. Virji, S. von Kleist, C. Wagener, S. Watt, and W. Zimmermann. 1991. Redefined nomenclature for members of the carcinoembryonic antigen family. Exp. Cell Res.252:243.
    OpenUrl
  2. 2.↵
    Bergmann, C. C., B. Parra, R. Hinton, R. Chandran, M. Morrison, and S. A. Stohlman. 2003. Perforin-mediated effector function within the central nervous system requires IFN-gamma-mediated MHC up-regulation. J. Immunol.170:3204-3213.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    Bergmann, C. C., B. Parra, D. R. Hinton, C. Ramakrishna, K. C. Dowdell, and S. A. Stohlman. 2004. Perforin and interferon gamma mediated control of coronavirus central nervous system infection by CD8 T cells in the absence of CD4 T cells. J. Virol.78:1739-1750.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    Blau, D. M., C. Turbide, M. Tremblay, M. Olson, S. Letourneau, E. Michaliszyn, S. Jothy, K. V. Holmes, and N. Beauchemin. 2001. Targeted disruption of the Ceacam1 (MHVR) gene leads to reduced susceptibility of mice to mouse hepatitis virus infection. J. Virol.75:8173-8186.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    Chen, D. S., M. Asanaka, K. Yokomori, F. Wang, S. B. Hwang, H. P. Li, and M. M. Lai. 1995. A pregnancy-specific glycoprotein is expressed in the brain and serves as a receptor for mouse hepatitis virus. Proc. Natl. Acad. Sci. USA92:12095-12099.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    Chen, W., and R. S. Baric. 1996. Molecular anatomy of mouse hepatitis virus persistence: coevolution of increased host cell resistance and virus virulence. J. Virol.70:3947-3960.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    Dveksler, G. S., C. W. Dieffenbach, C. B. Cardellichio, K. McCuaig, M. N. Pensiero, G. S. Jiang, N. Beauchemin, and K. V. Holmes. 1993. Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59. J. Virol.67:1-8.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    Fleming, J. O., M. D. Trousdale, F. El-Zaatari, S. A. Stohlman, and L. P. Weiner. 1986. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J. Virol.58:869-875.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    Gallagher, T. M., M. J. Buchmeier, and S. Perlman. 1992. Cell receptor-independent infection by a neurotropic murine coronavirus. Virology191:517-522.
    OpenUrlCrossRefPubMed
  10. 10.↵
    Godfraind, C., N. Havaux, K. V. Holmes, and J. P. Coutelier. 1997. Role of virus receptor-bearing endothelial cells of the blood-brain barrier in preventing the spread of mouse hepatitis virus-A59 into the central nervous system. J. Neurovirol.3:428-434.
    OpenUrlCrossRefPubMed
  11. 11.↵
    Greicius, G., E. Severinson, N. Beauchemin, B. Obrink, and B. B. Singer. 2003. CEACAM1 is a potent regulator of B cell receptor complex-induced activation. J. Leukoc. Biol.74:126-134.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    Kammerer, R., D. Stober, B. B. Singer., B. Obrink, and J. Reimann. 2001. Carcinoembryonic antigen-related cell adhesion molecule 1 on murine dendritic cells is a potent regulator of T cell stimulation. J. Immunol.166:6537-6544.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    Lane, T. E., M. T. Liu, B. P. Chen, V. C. Asensio, R. M. Samawi, A. D. Paoletti, I. L. Campbell, S. L. Kunkel, H. S. Fox, and M. J. Buchmeier. 2000. A central role for CD4+ T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J. Virol.74:1415-1424.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    Nakajima, A., H. Iijima, M. F. Neurath, T. Nagaishi, E. E. Nieuwenhuis, R. Raychowdhury, J. Glickman, D. M. Blau, S. Russell, K. V. Holmes, and R. S. Blumberg. 2002. Activation-induced expression of carcinoembryonic antigen-cell adhesion molecule 1 regulates mouse T lymphocyte function. J. Immunol.168:1028-1035.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    Ontiveros, E., T. S. Kim, T. M. Gallagher, and S. Perlman. 2003. Enhanced virulence mediated by the murine coronavirus, mouse hepatitis virus strain JHM, is associated with a glycine at residue 310 of the spike glycoprotein. J. Virol.77:10260-10269.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    Parra, B., D. R. Hinton, M. T. Lin, D. J. Cua, and S. A. Stohlman. 1997. Kinetics of cytokine mRNA expression in the central nervous system following lethal and nonlethal coronavirus-induced acute encephalomyelitis. Virology233:260-270.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    Phillips, J. J., M. M. Chua, E. Lavi, and S. R. Weiss. 1999. Pathogenesis of MHV-4/MHV-A59 recombinant viruses: the murine coronavirus spike protein is a major determinant of neurovirulence. J. Virol.73:7752-7760.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    Rao, P. V., and T. M. Gallagher. 1998. Intracellular complexes of viral spike and cellular receptor accumulate during cytopathic murine coronavirus infections. J. Virol.72:3278-3288.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    Sawicki, S. G., J. H. Lu, and K. V. Holmes. 1995. Persistent infection of cultured cells with mouse hepatitis virus (MHV) results from the epigenetic expression of the MHV receptor. J. Virol.69:5535-5543.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    Stohlman, S. A., A. Y. Sakaguchi, and L. P. Weiner. 1979. Characterization of the cold-sensitive murine hepatitis virus mutants rescued from latently infected cells by cell fusion. Virology98:448-455.
    OpenUrlCrossRefPubMed
  21. 21.↵
    Vassao, R. C., M. T. de Franco, D. Hartz, M. Modolell, A. E. Sippel, and C. A. Pereira. 2000. Down-regulation of Bgp1(a) viral receptor by interferon-gamma is related to the antiviral state and resistance to mouse hepatitis virus 3 infection. Virology274:278-283.
    OpenUrlCrossRefPubMed
  22. 22.↵
    Wang, F. I., D. R. Hinton, W. Gilmore, M. D. Trousdale, and J. O. Fleming. 1992. Sequential infection of glial cells by the murine hepatitis virus JHM strain (MHV-4) leads to a characteristic distribution of demyelination. Lab. Investig.66:744-754.
    OpenUrlPubMed
  23. 23.↵
    Williams, R. K., G.-S. Jiang, S. W. Snyder, M. F. Frana, and K. V. Holmes. 1990. Purification of the 110-kilodalton glycoprotein receptor for mouse hepatitis virus (MHV)-A59 from mouse liver and identification of a nonfunctional, homologous protein in MHV-resistant SJL/J mice. J. Virol.64:3817-3823.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    Yokomori, K., and M. M. Lai. 1992. Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. J. Virol.66:6194-6199.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    Yokomori, K., and M. M. Lai. 1992. The receptor for mouse hepatitis virus in the resistant mouse strain SJL is functional: implications for the requirement of a second factor for viral infection. J. Virol.66:6931-6938.
    OpenUrlAbstract/FREE Full Text
  26. 26.
    Yokomori, K., M. Asanaka, S. A. Stohlman, and M. M. Lai. 1993. A spike protein-dependent cellular factor other than the viral receptor is required for mouse hepatitis virus entry. Virology196:45-56.
    OpenUrlCrossRefPubMed
  27. 27.↵
    Zelus, B. D., D. R. Wessner, R. K. Williams, M. N. Pensiero, F. T. Phibbs, M. deSouza, G. S. Dveksler, and K. V. Holmes. 1998. Purified, soluble recombinant mouse hepatitis virus receptor, Bgp1(b), and Bgp2 murine coronavirus receptors differ in mouse hepatitis virus binding and neutralizing activities. J. Virol.72:7237-7244.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    Zhou, J., S. A. Stohlman, R. Atkinson, D. R. Hinton, and N. W. Marten. 2002. Matrix metalloproteinase expression correlates with virulence following neurotropic mouse hepatitis virus infection. J. Virol.76:7374-7384.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    Zhou, J., S. A. Stohlman, D. R. Hinton, and N. W. Marten. 2003. Neutrophils promote mononuclear cell infiltration during viral-induced encephalitis. J. Immunol.170:3331-3336.
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Expression of the Mouse Hepatitis Virus Receptor by Central Nervous System Microglia
Chandran Ramakrishna, Cornelia C. Bergmann, Kathryn V. Holmes, Stephen A. Stohlman
Journal of Virology Jun 2004, 78 (14) 7828-7832; DOI: 10.1128/JVI.78.14.7828-7832.2004

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Expression of the Mouse Hepatitis Virus Receptor by Central Nervous System Microglia
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Expression of the Mouse Hepatitis Virus Receptor by Central Nervous System Microglia
Chandran Ramakrishna, Cornelia C. Bergmann, Kathryn V. Holmes, Stephen A. Stohlman
Journal of Virology Jun 2004, 78 (14) 7828-7832; DOI: 10.1128/JVI.78.14.7828-7832.2004
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Carcinoembryonic Antigen
microglia
Murine hepatitis virus
Receptors, Virus

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514